Tim Sutton, Cardiologist Counties-Manukau DHB and Auckland Heart Group
|
|
- Blaze Butler
- 5 years ago
- Views:
Transcription
1 Tim Sutton, Cardiologist Counties-Manukau DHB and Auckland Heart Group
2 Exertional dyspnoea Orthopnea Paroxysmal nocturnal dyspnoea Oedema Third heart sound Elevated JVP Basal rales Swollen ankles
3
4 Temporal trend Effort tolerance NYHA classification Functional class Symptoms I No limitation of physical activity : Ordinary physical activity does not cause undue breathlessness, fatigue or palpitations II Slight limitation of physical activity : Comfortable at rest, but ordinary physical activity does not cause undue breathlessness, fatigue or palpitations III Marked limitation of physical activity : Comfortable at rest, but less than ordinary physical activity does not cause undue breathlessness, fatigue or palpitations IV Unable to carry on any physical activity without discomfort : Symptoms at rest can be present. If any physical activity is undertaken, discomfort is increased
5 ECG Chest X-ray Nt-proBNP : best done pre diuretic Rx / good renal function Baseline bloods FBC, U+Es, Glu, LFTs, INR, Albumen, TFTs and ferritin
6 1) Assess LV size and function Systolic and diastolic Regional vs global 2) Assess LV wall thickness 3) Assess valve function 4)Assess RV function
7 Dilated heart Normal size
8 Preserved EF Reduced EF
9 Above 50-55% Mild 40-50% Moderate 30-40% Under 30% severe Under 20% very severe
10
11 Regional Gobal
12 Symptoms typical of HF Signs of typical HF Reduced EF Symptoms typical of HF Signs of typical of HF Normal of mildly reduced EF and LV NOT dilated Relevant structural heart disease (LVH / LA enlargement) and / or diastolic dysfunction
13 Sudden decompensation Patient often euvolaemic right amount of fluid, just in the wrong place Transient rise in left atrial pressure causing lungs to flood with fluid (acute pulmonary oedema) Sub-acute / chronic decompensation Did the patient previously have a normal heart? Yes.. Gradual Ischaemia accumulation of fluid congestive state with generalised fluid retention (oedema) No Ischaemia / arrhythmia / increased afterload etc Hypervolaemia too much fluid all over the place
14 What is the cause of the heart failure? What has triggered the presentation? De novo diagnosis Decompensation secondary to: Natural history of underlying condition Intercurrent factor Anaemia Infection Drugs
15 Diagnosis : usually a chronic disease What is our treatment goal? Our aim is to keep you as well as we can for as long as we can, ideally leading as normal life as possible with no restrictions on what you can do, with as few pills as possible, but as many as are needed Non pharmacological
16 Exercise Diet weight loss in the obese, but beware the malnourished obese patient Salt restriction stick to the RDA! Minimise / avoid environmental cardiotoxins Alcohol Metamephetamine Smoking No place for fluid restriction except in exceptional situations
17 Is essential regular : daily exercise improves well being and A survival person should put aside some part of the day for the care of his Avoid extremes body. of dynamic He should exercise always make only sure mild static exercise that he gets enough exercise Patient can engage especially in a before formal a exercise meal." program moderate intensity aerobic vs high intensity interval training
18 Diagnosis : usually a chronic disease What is our treatment goal? Our aim is to keep you as well as we can for as long as we can, ideally leading as normal life as possible with no restrictions on what you can do, with as few pills as possible, but as many as are needed Non pharmacological Pharmacological
19 Loop diuretics Use dose that maintains the patient oedema free Relieve dyspnoea, but usually do not need high doses Monitor for side effects Renal dysfunction / electrolyte derangement / gout
20 ACE inhibitor / Angiotensin receptor blocker Any patient with impaired systolic function Optimal dose depends on agent Cilazapril 2.5mg (od) Quinapril 10mg (bd) Losartan 50mg (od) Candesartan 16mg (od) Monitor renal function and electrolytes
21 Start when euvolaemic Start low and go slow (increase every 2 weeks) Warn patient may feel slight worse for a few days If more breathless increase diuretic dose : sx should settle Aim for maximum tolerated dose Metoprolol CR 190mg (od) Carvedilol 25mg (bd) Bisoprolol 10mg (od)
22 When is dose optimised for an individual? When maximum dose reached When heart rate in low 50s Hypotensive symptoms Can Beta-blockers be used in airways disease? Generally yes survival benefit offsets risk : see improvement in lung function Not in brittle asthmatics / marked airway hyper-reactivity
23 Fatigue but you can still do more than pre Rx? Hypotensive Sx try and cut the other meds Erectile dysfunction agents to assist
24 Who: Anyone with symptomatic heart failure due to impaired systolic function Dose : Spironolactone (12.5mg), 25mg aim 50mg Eplerenone (25mg) 50mg aim 100mg Monitor for side effects Renal dysfunction / hyperkalaemia
25
26 Maximum tolerated doses of ACEi / ARB Beta blocker Aldosterone receptor antagonist +/- diuretic
27 Fluid status Weight JVP Lungs Oedema Postural BP Renal function Hypervolaemia Climbing High Rales Present May be a rise with standing Euvolaemia Stable Stable may be high if TR Stable / worse Clear Absent No drop Stable Hypovolaemia Falling Low Clear Absent Present Climbing
28 Digoxin reduces hospitalisation, but not survival Amiodarone only for symptomatic arrhythmia, otherwise shortens life Ivabradine (not in NZ yet) improves survival in those on optimal dose beta-blocker and HR >77bpm at rest Nitrate and hydralazine Very old school!
29 Is more common in:- Elderly Females Obesity / diabetes / hypertension Is the commonest cause of pulmonary hypertension in the elderly Prognosis just as bleak as for systolic dysfunction
30 Stiff, non compliant heart : squeezes OK, but does not fill well At rest is usually fine, but anything that increases heart rate can causes symptoms Infection / anaemia / metabolic derrangement Exercise Atrial arrhythmias
31 Prevention is better than needing to actually treat! No proven Rx once established Low dose diuretics Negative chronotropes to slow heart Spironolactone if Nt-BNP high (>300) and symptoms
32 Polypharmacy with potential side effects Takes 3-6 months to get right Drs much better with HF-ReF than HF-PeF! Treatment is usually for life There is a risk to suddenly stopping medication There is a risk to not taking pills and then taking OMT doses Multiple contacts with medical system Nurse / primary and secondary care
33 Diagnosis : usually a chronic disease What is our treatment goal? Our aim is to keep you as well as we can for as long as we can, ideally leading as normal life as possible with no restrictions on what you can do, with as few pills as possible, but as many as are needed Non pharmacological Pharmacological Prognosis /general issues that may not be apparent initially
34 In the absence of contraindications offered to Anyone who has survived a sudden cardiac death Has poorly tolerated VT / LV impairment and syncope that is unexplained Anyone who has been on and adherent to OMT for three months and has EF of under 30% if non ischaemic CM EF of under 35% if ischaemic CM Malignant familial history / genotype
35 An ICD is permanent It is not an active therapy : it will not make the patient feel better An ICD does not alter the natural history of the underlying disease one day pump failure will predominate and consideration should be given programming shock therapy off Not everyone wants an ICD they do come with risks
36 The patient should contact / attend their ICD clinic ICD will be read and rhythm reviewed May be a change in ICD settings The patient cannot drive a car for 6 months There may be a period of emotional lability / depression or even post traumatic stress disorder (more common after ICD storms)
37 Not very common to see, but this will change over time Improves symptoms and survival
38 Wairua (Spiritual health) Whanau (Family) Tinana (Physical Health) Hinengaro (Mental health)
39 Class 1 or 6: Driving OK unless very symptomatic Class 2,3,4,5 or P endorsement: Generally individuals will be unfit to drive special dispensation is available
40 If can mount 2 flights of stairs, reasonably quickly, without too much problem then sex should be fine. Keep GTN available (not with Viagra though). Activity is least likely to cause symptoms if engaged in after a good night s sleep and with the least affected partner doing most of the work Viagra is safe Patient plus website
41 Uncontrolled AF can cause heart failure AF induced tachycardiomyopathy Rate Rx vs restoration of SR The onset of AF can cause decompensation of a previously stable cardiac condition
42 Anticoagulation (in the absence of contraindications) is a must Warfarin NOAC: Dabigatran, Rivaroxiban, Apixiban Good rate Rx important Beta blocker Digoxin Amiodarone Ideally avoid diltiazem Interventional Rx : pulmonary vein isolation / CRT and AV nodal ablation
43 Only Rx aspirin / clopidogrel if proven vascular disease Anticoagulation with warfarin (INR 2-3) or NOAC for Any proven AF Any patient with impaired EF and embolic event when in SR Documented LV thrombus
44 Renal dysfunction is common in patients with heart failure (Cardiorenal syndrome) Multiple factors contribute Renal dysfunction can improve with treatment of heart failure Renal dysfunction in heart failure is not a contraindication for an ACEi / ARB, but a reason for caution can use spironolactone, but only with specialist input due to risk of hyperkalaemia Balance risk of a slight worsening in renal function against benefits of cardioprotective agents
45 Actively treat iron deficiency Oral iron replacement may not be effect Iron infusion excellent way of treating No clear role for EPO or analogues as yet may be harmful
46 Commonly coexist Central sleep apneoa common in CHF and treatment of CHF can improve it OSA common cannot easily assess until on OMT Baseline and post Rx ESS can be useful
47 Variable data Reasonable to continue if one is on a statin Start if have ACS / high CV risk But otherwise just another pill, especially in advanced heart failure
48 Address the underlying cause as best as possible often multifactorial Correct the reversible especially hypoxia Optimise Rx for left heart disease
49
50 Aries Taurus Gemini Cancer Leo Virgo Libra Scorpio Sagittarius Capricorn Aquarius Pisces Avoid incisions in the head and face and cut no vein in the head. Avoid incisions in the neck and throat and cut no veins there. Avoid incisions in the shoulders, arms or hands and cut no vein. Avoid incisions in the breasts, sides, stomach and lungs and cut no vein that goes to the spleen. Avoid incisions of the nerves, lesions of the sides and bones,and do not cut the back either by opening and bleeding. Avoid opening a wound in the belly and in the internal parts. Avoid opening wounds in the umbellicus and parts of the belly and do not open a vein in the back or do cupping. Avoid cutting the testicles and anus. Avoid incisions in the thighs and fingers and do not cut blemishes and growths. Avoid cutting the knees or the veins and sinews in these places. Avoid cutting the knees or the veins and veins in these places. Avoid cutting the feet.
51
52
53
54 Address the underlying cause as best as possible often multifactorial Correct the reversible especially hypoxia Optimise Rx for left heart disease Diuretics Best taken on empty stomach, 30 minutes before food Frusemide vs bumetanide Oral vs IV Spironolactone Metolazone use cautiously and watch electrolytes
55 Important to identify disease progression Review medications any room to push further Acknowledge disease progression this is not a failure of treatment, rather the natural history of the underlying disease Any non essential medications that could be stopped Advanced care planning : review ICD status if present Advanced stages of heart failure are unpredictable and patients can survive months to years with advanced Sx / poor prognostic markers aim is to ensure they remain well, but not to prolong suffering
56 Patients with suspected heart failure newly diagnosed Patients with known heart failure who are Deteriorating sub-acute vs chronic Running into problems with medication side effects New onset AF
57 Help further establish diagnosis and cause of heart failure Help initiate Rx and optimise Rx Discuss diagnosis and provide education Help establish chronic management plan Offer support through the early phase of the disease management Provide follow up once on OMT usually annual
58 Community Review patients in their own enviroment / clinic Check for polypharmacy drug inconsistencies Once stable 3 monthly review : Check adherence to Rx and side effects Review obs and weight chart Lifestyle and psychosocial issues Preventative programme : flu jab
Heart Failure Clinician Guide JANUARY 2016
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.
More informationAdvanced Heart Failure Management. Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary
Advanced Heart Failure Management Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary Grading of heart failure Mr WY age 73 3/12 dyspnoea, fatigue and some ankle oedema PMH: hypertension
More informationHeart Failure Clinician Guide JANUARY 2018
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.
More informationCardiology. Presented by: Dr Paul Bethell GP Lead for Planned Care
Cardiology Presented by: Dr Paul Bethell GP Lead for Planned Care 16 th April 2015 Integrated Cardiology Service for Ipswich and East Suffolk CCG IHT 6 consultants - all with specialist areas PCI CoW rapid
More informationHEART FAILURE. Study day November 2018 Sarah Briggs
HEART FAILURE Study day November 2018 Sarah Briggs Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology of heart failure
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationChronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology
Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center
More informationHeart Failure Update John Coyle, M.D.
Heart Failure Update 2011 John Coyle, M.D. Causes of Heart Failure Anderson,B.Am Heart J 1993;126:632-40 It It is now well-established that at least one-half of the patients presenting with symptoms and
More information8:30-10:30 WS #4: Cardiology :00-13:00 WS #11: Cardiology 101 (Repeated)
Professor Ralph Stewart Cardiologist Auckland City Hospital Green Lane Cardiovascular Research Unit Auckland Heart Group Fiona Stewart Cardiologist Green Lane Hospital National Women's Hospital Professor
More informationAtrial Fibrillation and Heart failure
Atrial Fibrillation and Heart failure and a bit about anticoagulation Tim Sutton, Consultant Cardiologist Middlemore Hospital, Manukau City and Auckland Heart Group Why Does AF Cause Heart Failure Impaired
More informationESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response
More informationChronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.
Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center
More informationChronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.
Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center
More informationAtrial Fibrillation Cases. Dr Paul Broadhurst Consultant Cardiologist
Atrial Fibrillation Cases Dr Paul Broadhurst Consultant Cardiologist November 2011 Mr TH age 72 Routine medical for hypertension check Denies any symptoms despite close questioning PMH: hypertension, MI,
More informationAtrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency
Atrial Fibrillation A guide for Southwark General Practice Key Messages 1. Routinely offer pulse checks to patients at high risk of AF 2. Use the CHA 2 DS 2 VASc score to identify patients for anticoagulation
More informationHeart Failure in 2012 with reference to NICE Guidance Dr Maurice Pye Consultant Cardiologist York District Hospital
Heart Failure in 2012 with reference to NICE Guidance 2010 Dr Maurice Pye Consultant Cardiologist York District Hospital A little over elaborate,do not include ECG or CXR If clinical suspicion is high
More informationThe NEW Heart Failure Guidelines
The NEW Heart Failure Guidelines Daily Practice HF scenario of the Case Presentations HF as a complex and heterogeneous syndrome Several proposed pathophysiological mechanisms involving the heart and the
More informationHeart Failure. Jay Shavadia
Heart Failure Jay Shavadia Definition Clinical syndrome characterized by: Symptoms: breathlessness at rest or on exercise, fatigue, tiredness or ankle swelling AND Signs: tachycardia, tachypnea, pulmonary
More informationThe Failing Heart in Primary Care
The Failing Heart in Primary Care Hamid Ikram How fares the Heart Failure Epidemic? 4357 patients, 57% women, mean age 74 years HFSA 2010 Practice Guideline (3.1) Heart Failure Prevention A careful and
More informationHeart Failure from a GP perspective
Heart Failure from a GP perspective Jane Gilmour, Alison Wright Clinical Nurse Specialists for Heart Failure The Heart failure Team Dr Ganesan Kumar- Consultant Cardiologist Dr D Maras- Staff Grade Cardiology
More informationUpdates in Congestive Heart Failure
Updates in Congestive Heart Failure GREGORY YOST, DO JOHNSTOWN CARDIOVASCULAR ASSOCIATES 1/28/2018 Disclosures Edwards speaker on Sapien3 valves (TAVR) Stages A-D and NYHA Classes I-IV Stage A: High risk
More informationArrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh
Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Ventricular Supraventricular VT/VF Primary prevention
More informationNora Goldschlager, M.D. SFGH Division of Cardiology UCSF
CLASSIFICATION OF HEART FAILURE Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF DISCLOSURES: NONE CLASSIFICATION C OF HEART FAILURE NYHA I IV New paradigm Stage A: Pts at high risk of developing
More informationA patient with decompensated HF
A patient with decompensated HF Professor Michel KOMAJDA University Pierre & Marie Curie Pitie Salpetriere Hospital Department of Cardiology Paris (France) Declaration Of Interest 2010 Speaker : Servier,
More informationDiastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012
Diastolic Heart Failure Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012 Disclosures Have spoken for Merck, Sharpe and Dohme Sat on a physician advisory
More informationHeart Failure. Dr. William Vosik. January, 2012
Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment
More informationUpdate on pharmacological treatment of heart failure. Aldo Pietro Maggioni, MD, FESC ANMCO Research Center Firenze, Italy
Update on pharmacological treatment of heart failure Aldo Pietro Maggioni, MD, FESC ANMCO Research Center Firenze, Italy Presenter Disclosures Dr. Maggioni : Serving in Committees of studies sponsored
More informationOutline. Chronic Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.
Chronic Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center Scientific
More informationAF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire
AF and arrhythmia management Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire Atrial fibrillation Paroxysmal AF recurrent AF (>2 episodes) that
More informationSummary/Key Points Introduction
Summary/Key Points Introduction Scope of Heart Failure (HF) o 6.5 million Americans 20 years of age have HF o 960,000 new cases of HF diagnosed annually o 5-year survival rate for HF is ~50% Classification
More informationChronic heart failure: management of chronic heart failure in adults in primary and secondary care (partial update)
Chronic heart failure: management of chronic heart failure in adults in primary and secondary care (partial update) NICE guideline Apendix C The algorithms Draft for consultation, January 2010 Chronic
More informationDiagnosis and management of chronic heart failure
Quick reference guide for health professionals Diagnosis and management of chronic heart failure Updated October 2011 This quick reference guide is derived from the National Heart Foundation of Australia
More informationControversies in Atrial Fibrillation and HF
Controversies in Atrial Fibrillation and HF Dr.Yahya Al Hebaishi Cardiac electrophysiology division, PSCC, Riyadh Atrial Fibrillation: Rate or Rhythm? HF and AF: the twin epidemic of cardiovascular disease.
More informationkeyword: diuretics Drug monitoring Monitoring diuretics in primary care 2 March 2009 best tests
www.bpac.org.nz keyword: diuretics Drug monitoring Monitoring diuretics in primary care 2 March 2009 best tests Why do we monitor patients taking diuretics and what do we monitor? Monitoring a person on
More informationChronic. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Michael G. Shlipak, MD, MPH
Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center
More informationInverclyde CHP Protected Learning Event- Heart Failure
Inverclyde CHP Protected Learning Event- Heart Failure 14:00 14:05 14:05 14:20 14:20 14:30 14:30 15:10 15:10 15:30 15:30 15:50 15:50 16:05 16:05 16:35 Welcome & Introduction Paul Forsyth (HF Pharmacist)
More informationLITERATURE REVIEW: HEART FAILURE. Chief Residents
LITERATURE REVIEW: HEART FAILURE Chief Residents Heart Failure EF 40% HFrEF Problem with contractility EF 40-50% HFmrEF EF > 50% HFpEF Problem with filling/relaxation RISK FACTORS Post MI HTN DM Obesity
More informationHeart Failure (HF) - Primary Care Flow Charts. Pre diagnosis Symptoms or signs suggestive of HF
Heart Failure (HF) - Primary Care Flow Charts Pre diagnosis Symptoms or signs suggestive of HF 12 lead ECG Normal examination and 12 lead ECG HF highly unlikely Abnormal 12 lead ECG HF Possible Arrange
More informationHeart Failure (HF) - Primary Care Flow Charts. Symptoms or signs suggestive of HF. Pre diagnosis. Refer to the Heart Failure Clinic at VHK for
Heart Failure (HF) - Primary Care Flow Charts Pre diagnosis Symptoms or signs suggestive of HF 12 lead ECG Normal examination and 12 lead ECG HF highly unlikely Abnormal 12 lead ECG HF Possible Arrange
More informationHEART FAILURE. Study day November 2017 Sarah Briggs and Janet Laing
HEART FAILURE Study day November 2017 Sarah Briggs and Janet Laing Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology
More informationDiagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham
Diagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Chronic heart failure
More informationWHAT IS CONGESTIVE HEART FAILURE?
WHAT IS CONGESTIVE HEART FAILURE? Congestive heart failure (CHF) is a term used to describe the heart s inability to pump enough blood to meet the body s needs. Heart failure does not mean that the heart
More informationIntroduction to Heart Failure. Mauricio Velez, M.D. Transplant Cardiologist APACVS 2018 April 5-7 Miami, FL
Introduction to Heart Failure Mauricio Velez, M.D. Transplant Cardiologist APACVS 2018 April 5-7 Miami, FL Disclosures No relevant financial relationships to disclose Objectives and Outline Define heart
More informationCost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib
Atrial Fibrillation: Guideline Directed Treatment Melissa Wendell, FNP-C, MSN Heart Failure - Lead Nurse Practitioner, Aspirus Wausau Hospital and Aspirus Cardiology Cost and Prevalence of A fib 33.5 million
More informationDr Emma Copsey Consultant Cardiologist Glenfield Hospital 28 th September 2017
Dr Emma Copsey Consultant Cardiologist Glenfield Hospital 28 th September 2017 Educational Objectives Objectives To review the GIM & Cardiology syllabus for HF To review the new nomenclature/classification
More informationNT-proBNP: Evidence-based application in primary care
NT-proBNP: Evidence-based application in primary care Associate Professor Rob Doughty The University of Auckland, Auckland City Hospital, Auckland Heart Group NT-proBNP: Evidence in Primary Care The problem
More informationTopic Page: congestive heart failure
Topic Page: congestive heart failure Definition: congestive heart f ailure from Merriam-Webster's Collegiate(R) Dictionary (1930) : heart failure in which the heart is unable to maintain an adequate circulation
More informationDefinition of Congestive Heart Failure
Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million
More informationManagement of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
More informationHEART FAILURE SUMMARY. and is associated with significant morbidity and mortality. the cornerstone of heart failure treatment.
HEART FAILURE SUMMARY + Heart Failure is a condition affecting a large number of Irish people and is associated with significant morbidity and mortality. + ACE inhibitors, in combination with diuretics,
More informationThe Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician
The Atrial Fibrillation Clinic in Llanelli Dr Lena Marie Izzat Consultant Cardiovascular Physician Llanelli Multidisciplinary AF Clinic Went live January 2009 Based on the fact that Carmarthenshire has
More informationHeart Failure Treatments
Heart Failure Treatments Past & Present www.philippelefevre.com Background Background Chronic heart failure Drugs Mechanical Electrical Background Chronic heart failure Drugs Mechanical Electrical Sudden
More informationPeripartum Cardiomyopathy. Lavanya Rai Manipal
Peripartum Cardiomyopathy Lavanya Rai Manipal Definition - PPCM - Dilated cardiomyopathy of unknown cause resulting in cardiac failure that occurs in the peripartum period in women without any preexisting
More informationHeart Failure A Disease for the Internist?
Heart Failure A Disease for the Internist? Dr Chris Davidson Sussex Cardiac Centre BRIGHTON UK Hot Topics in Heart Failure Drug treatments Valsartan / neprilysin inhib Investigations BNP and others Devices
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationThe Patient Journey through Heart Failure Primary Care Handout
The Patient Journey through Heart Failure Primary Care Handout Dr Ameet Bakhai Consultant Cardiologist - 2015 Background Observed 5 year survival rates for heart failure patients are 26-52% worse than
More informationCoronary Heart Disease. Iqbal Malik
Coronary Heart Disease Iqbal Malik Pathophysiology IHD Case chest pain Question -interactive What is the result of the exercise test? 1. negative 2. positive 3. equivocal 4. other Q2 answer STEMI! What
More informationThis information explains heart failure, including causes and signs of heart failure, how heart failure is diagnosed, and how it s treated.
PATIENT & CAREGIVER EDUCATION Heart Failure This information explains heart failure, including causes and signs of heart failure, how heart failure is diagnosed, and how it s treated. About Heart Failure
More informationHeart Failure update. Key messages. Aim of the guideline NOVEMBER 2015 SUMMARY GUIDELINES. Optimise treatment with beta-blockers and ACE/ARB.
SUMMARY GUIDELINES NOVEMBER 2015 Heart Failure update Key messages Aim of the guideline Optimise treatment with beta-blockers and ACE/ARB. Rapid referral of patients with suspected heart failure and previous
More informationMedical management of LV aneurysm and subsequent cardiac remodeling: is it enough? J. Parissis Attikon University Hospital Athens, Greece
Medical management of LV aneurysm and subsequent cardiac remodeling: is it enough? J. Parissis Attikon University Hospital Athens, Greece Disclosures Grants: ALARM investigator received research grants
More informationState-of-the-Art Management of Chronic Systolic Heart Failure
State-of-the-Art Management of Chronic Systolic Heart Failure Michael McCulloch, MD 17 th Annual Cardiovascular Update Intermountain Medical Center December 16, 2017 Disclosures: I have no financial disclosures
More informationStroke Prevention & Atrial Fibrillation. Susanne Christie Arrhythmia Nurse Specialist 24 th September 2015
Stroke Prevention & Atrial Fibrillation Susanne Christie Arrhythmia Nurse Specialist 24 th September 2015 Learning Outcomes What is Atrial Fibrillation? Why is Atrial Fibrillation important? What causes
More informationCongestive Heart Failure: Outpatient Management
The Chattanooga Heart Institute Cardiovascular Symposium Congestive Heart Failure: Outpatient Management E. Philip Lehman MD, MPP Disclosure No financial disclosures. Objectives Evidence-based therapy
More informationCARDIAC REHABILITATION PROGRAMME:- MEDICATION
CARDIAC REHABILITATION PROGRAMME:- MEDICATION AIM OF THIS SESSION Understand the reasons for taking your medications, Discuss the common side effects associated with these medications - knowing when to
More informationARNI (Angiotensin Receptor blocker / Neprilysin Inhibitors [Sacubutril/Valsartan]) Heart Failure Medication Initiation and Titration
ARNI (Angiotensin Receptor blocker / Neprilysin Inhibitors [Sacubutril/Valsartan]) Heart Failure Medication and Symptomatic HF despite ACEI/ARB and B-blocker therapy Bilateral renal artery stenosis Moderate/Severe
More informationHEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014
HEART FAILURE Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center March 2014 Heart Failure in the US Prevalence - ~5 million 650,000 new cases annually 300,000 deaths annually Leading
More informationCLINICAL PRACTICE GUIDELINE
CLINICAL PRACTICE GUIDELINE Procedure: Congestive Heart Failure Guideline Review Cycle: Biennial Reviewed By: Amish Purohit, MD, MHA, CPE, FACHE Review Date: November 2014 Committee Approval Date: 11/12/2014
More informationBSH Heart Failure Day for Revalidation and Training 2017
BSH Heart Failure Day for Revalidation and Training 2017 Presentation title: Case Presentation cardio-oncology Speaker: Mark Drury-Smith Conflicts of interest: None British Society of Heart Failure 2017
More informationChecklist for Treating Heart Failure. Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute
Checklist for Treating Heart Failure Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute Novartis Disclosure Heart Failure (HF) a complex clinical syndrome that arises secondary to abnormalities
More informationIschaemic Heart Disease
Ischaemic Heart Disease Katherine Rothwell Case 1 65 yr old female PMHx : Eczema, is a smoker 20/day Comes to see you complaining of central chest pain Present past few months. Comes on when gardening
More informationManagement of Heart Failure from diagnosis to the grave. Richard Lawrance Consultant Cardiologist - WMH
Management of Heart Failure from diagnosis to the grave Richard Lawrance Consultant Cardiologist - WMH Case Presentation 55y man Breathless Ex tolerance 100yds on flat, limited by SOB No chest pain Borderline
More informationIncidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction
Heart Failure Diagnosis According to the Working Group in Heart Failure, CHF is a syndrome where the diagnosis has the following essential components: A combination of: Symptoms, typically breathlessness
More informationATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION
ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION Frederick Schaller, DO, MACOI,FACP Adjunct Clinical Professor Touro University Nevada DISCLOSURES I have no financial relationships
More informationHeart Failure in Women
Heart Failure in Women Disclosure Professor Sindone has received honoraria, speaker fees, consultancy fees, is a member of advisory boards or has appeared on expert panels for: Professor Andrew Sindone
More informationHeart Failure: Guideline-Directed Management and Therapy
Heart Failure: Guideline-Directed Management and Therapy Guideline-Directed Management and Therapy (GDMT) was developed by the American College of Cardiology and American Heart Association to define the
More informationPharmacological Treatment for Chronic Heart Failure. Dr Elaine Chau HK Sanatorium & Hospital, Hong Kong 3 August 2014
Pharmacological Treatment for Chronic Heart Failure Dr Elaine Chau HK Sanatorium & Hospital, Hong Kong 3 August 2014 1 ACC/AHA 2005 guideline update for Diagnosis & management of CHF in the Adult -SA Hunt
More informationImages have been removed from the PowerPoint slides in this handout due to copyright restrictions.
Heart Failure Heart Failure Introduction and History AHA 2015 Statistics About 6 million Americans 870,000 new cases each year 1 in 9 deaths related to HF Almost 1 million hospitalizations each year (cost
More informationHeart Failure Dr ahmed almutairi Assistant professor internal medicin dept
Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept (MBBS)(SBMD) Introduction Epidemiology Pathophysiology diastolic/systolic Risk factors Signs and symptoms Classification of HF
More informationEvaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF<40%
Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF
More information1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?
Disclosure Heart Failure Guideline Review and Update I have had no financial relationship over the past 12 months with any commercial sponsor with a vested interest in this presentation. Natalie Beiter,
More informationMedical management of AF: drugs for rate and rhythm control
Medical management of AF: drugs for rate and rhythm control Adel Khalifa Sultan Hamad, BMS, MD, FGHRS, FRCP(Canada) Consultant Cardiologist & Interventional Cardiac Electrophysiologist Head of Electrophysiology
More informationHEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
HEART FAILURE PHARMACOLOGY University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 LEARNING OBJECTIVES Understand the effects of heart failure in the body
More informationWhat s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE. Marc Ferrini (Lyon Fr)
What s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE Marc Ferrini (Lyon Fr) Palermo (I) 1 04 2017 Consulting Fees, Honoraria: BAYER PHARMA BOEHRINGER INGELHEIM BRISTOL MEYERS
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Is there a mortality risk associated with aspirin use in heart failure? Results from a large community based cohort Margaret Bermingham, Mary-Kate Shanahan, Saki Miwa,
More informationInnovation therapy in Heart Failure
Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure
More informationCardiovascular Clinical Practice Guideline Pilot Implementation
Cardiovascular Clinical Practice Guideline Pilot Implementation Pharmacologic Management of Chronic Heart Failure Sept 15, 2004 Angela Allerman, PharmD, BCPS DoD Pharmacoeconomic Center Promoting high
More informationHeart Failure. Disclosures. Objectives: 8/28/2017. This is not a virus. It doesn t go away. none
Heart Failure This is not a virus. It doesn t go away Shelley Wojtaszczyk, FNP-C, CHFN Heart Failure Program Coordinator Mercy Hospital of Buffalo none Disclosures Objectives: Defining and identifying
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF CHRONIC HEART FAILURE with left ventricular systolic dysfunction
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF CHRONIC HEART FAILURE with left ventricular systolic dysfunction o o o o o All heart failure patients with LVSD should be considered for
More informationAkash Ghai MD, FACC February 27, No Disclosures
Akash Ghai MD, FACC February 27, 2015 No Disclosures Epidemiology Lifetime risk is > 20% for American s older than 40 years old. > 650,000 new cases diagnosed each year. Incidence increases with age: 2%
More informationCardiovascular Pharmacotherapy
Cardiovascular Pharmacotherapy Overview Mechanism of cardiovascular drugs Indications and clinical use in cardiology Renin-Angiotensin Inhibitors: Angiotensin-Converting Enzyme Inhibitors, Angiotensin
More informationHeart failure: Local solutions for a growing problem
Heart failure: Local solutions for a growing problem Dr Andrew Hannah Consultant Cardiologist ARI What is heart failure? A clinical syndrome comprising of dyspnoea, fatigue or fluid retention due to cardiac
More informationCongestive Heart Failure or Heart Failure
Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?
More informationCharles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT
Charles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT Key Messages Heart Failure is Common Heart failure is complex Heart Failure is a major issue for the NHS Heart Failure has a worse prognosis
More informationRESTRICTIVE CARDIOMYOPATHY
RESTRICTIVE CARDIOMYOPATHY Restrictive cardiomyopathy (RCM) is a rare form of heart muscle disease that is characterized by restrictive filling of the ventricles. In this disease the contractile function
More informationICD deactivation Patient Journey
ICD deactivation Patient Journey Julia decourcey Consultant Nurse Kings College Hospital 05.05.10 Internal Cardiac Defibrillator Used in pts at high risk of sudden cardiac death ie EF > 30% Previous survivor
More informationAtrial Fibrillation Management in the ED. J Fisher May 2014"
Atrial Fibrillation Management in the ED J Fisher May 2014" A 48 yr old man presents with palpitations. He had a big night last night with old mates. ECG How will you manage him? Why important? Common
More informationHeart Failure with Preserved EF (HFPEF) Epidemiology and management
Heart Failure with Preserved EF (HFPEF) Epidemiology and management Karl Swedberg Senior Professor of Medicine Sahlgrenska Academy University of Gothenburg Gothenburg, Sweden e-mail: karl.swedberg@gu.se
More informationMedical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011
Medical Treatment for acute Decompensated Heart Failure Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011 2010 HFSA guidelines for ADHF 2009 focused update of the 2005 American College
More informationRhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014
Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014 Financial disclosures Consultant Medtronic 3 reasons to evaluate and treat arrhythmias
More information